Opening paragraph (optional); Current state of the enterprise description; Wonderland Laboratories is driven to discover and deliver diagnostic insights that help improve human health. Wonderland is currently based in northern California. It is California’s leading provider of single molecule counting (SMC) technology for clinical diagnostics. Wonderland 's patented SMC technology allows physicians to detect biomarkers of disease that were previously undetectable. With the help of SMC technology, Wonderland 's laboratory testing services are transforming reactionary patient treatment to proactive health management. The ultra-sensitive immunoassay technology powered by SMC enhances the clinical value of biomarkers associated with cardiovascular disease. The laboratory performs medical tests that exist to help with disease diagnosis, disease progression/recovery, as well as disease-free confirmation. Better results support better patient care. Wonderland Laboratory’s advanced clinical laboratory tests are used to assess a patient’s health risks, providing earlier detection and monitoring of disease over time. For example, a physician can determine a patient’s heart disease risk prior to the occurrence of an event, such as a heart attack. The comprehensive test reports help physicians effectively manage chronic disease and monitor disease progression—so treatment is customized to patient’s risks and needs. Additional tests in other chronic disease areas are currently
• Blood tests or other screening tests to check for autoimmune diseases, such as thyroid disease or diabetes.
Ms. Sunshine had blood work sent known as cardiac markers. The labs individually are creatine phosphokinase (CPK), CPK-MB (a type of CPK specific to myocardium), and troponin.
Joint Commission International, Centers for Medicare and Medicaid Services (CMS), Lab is accredited by College of American Pathologist (CAP) (K.E., personal communication, 2016).
The Merck Manual (2013) highlights the serum lipid profile as the most common diagnostic tool to identify hyperlipidaemia. This measures the total cholesterol, triglycerides, HDLs, LDLs and VLDLs. However, the test should be conducted after the illness has been treated because triglycerides, lipoproteins and cholesterol may be lower due to the body being in an inflammatory state. If there are high LDL levels, lipoprotein(a) and C-reactive protein levels can also be measured in the blood. Those with high triglyceride levels may also have LDL particle number or apoprotein B-100 measurements taken.
Once the health problems had been rated the “Pearl” Test was performed to “screen out health problems based on the following the feasibility factors” (archived.naccho.org, n.d.:
This set of particular tests were carried out at Manchester Metropolitan University in the Interdisciplinary Laboratory. Prior to the tests that were going to be carried out the client in question was asked to carry out a Pre-Test Medical questionnaire to assess the risks involved and to see if the client would be able to participate in the tests. The tests that were performed on the client were height, weight, haemoglobin, cholesterol, FEV1 and FVC.
To take blood tests for diagnosis Human blood is comprised of components paramount to medical diagnosis. With blood tests, it is now possible to detect illnesses, measure a patient’s response to medication or treatment, and lastly assess if a patient is receiving proper nutrition. More substantially, this practical procedure can easily diagnose bacterial infections, cholesterol levels, and even more crucial to some types of cancer. Likewise, routine blood tests sometimes even reveal potential health episodes such as strokes and heart attacks. To monitor expecting mothers and
IDC MarketScape: “U.S. Healthcare Provider Clinical and Financial Analytics Standalone Platform Vendor Assessment, doc #HI255139, April 2015.” named Explorys as the leader among the 12 vendors that were evaluated (Figure 3). Explorys [4] is a secure, cloud-based analytics platform that leverages big data for clinical integration, predictive analytics, and business intelligence. It has been adopted by 26 major integrated healthcare networks with 315 billion data elements, 50 million unique cared-for-lives, 360 hospitals, and 317,000 providers who collectively deliver $69B in care annually.
After discovering my passion for science and math, I pursue a career in Clinical Laboratory Science with enthusiasm. My desire to study this subject originates from the exciting and rapidly-moving subject area that is highly relevant to major issues facing society today. Clinical Laboratory Scientists play a crucial role in the healthcare field; in detection, diagnosis and treatment of disease in patients. My goal is to be involved in the latest advances in medical research and to constantly be expanding my knowledge about my field. On top of this goal, Clinical Laboratory Science remains a challenging, rewarding and inspiring topic that will motivate and shape my career for my entire life.
With BioReference Laboratories, Inc. impact of being the third largest integrated clinical diagnostic laboratory in the United States, they have inherited excellent customers satisfaction from their clients over the years for the services they provide by the leadership management of organization promoting quality services at reduced cost along with speedy and flexible overall performance (BioReference Laboratories, Inc.,
In today’s society, people are gaining medical knowledge at quite a fast pace. Treatments, cures, and vaccines for various diseases and disorders are being developed constantly, and yet, coronary disease remains the number one killer in the world.
An advantage of the test was that the blood samples used are one of the leading analysis preferences chosen to identify biomarkers, and easily obtainable from patients. However, as direct assay was unavailable, Bromocresol green solution was used which changed the electronic structure thus specific whilst binding to albumin. As a result, this generates accurate results with no anomalies for both serum and blood. Moreover, within the expense limitations of University of Chester, a simple assay was used (Rehm, 2006) expands that BCA assay may have been used
important test of an individuals physical health since unhealthy levels can lead to heart attacks,
Unlike Gilead that has only one product in its Oncology line, Bristol-Myers Squibb presently have four different drugs namely: Erbitux –an epidermal growth factor receptor (EGFR) antagonist for the treatment of Head & Neck cancer and Colorectal cancer,(2) Opdivo (nivolumab) for the treatment of unresectable or metastic melanoma and lungs cancer, (3) Syrcel( dasatinb) for the treatment of newly diagnosed adult with Philadelphia chromosome –positive (ph+) chronic myeloid leukemia and (4) Yervoy (ipilimumob) for the treatment of melanoma a type of skin cancer that spread and as such cannot be remove by surgery. Like Seattle Genetics, the company products use either Antibody-drug Conjugate (ADC) though in a different version by linking potent cytotoxic to monoclonal antibodies targeted to specific tumor cells or immune-oncology, an innovative technology that unlocks the body own immune system to fight against cancerous cells. It also expanded its focus to Nolch inhibitor (used in blocking powerful pathway that promotes tumor cell survival for certain other types of cancer. (Bristol-Myer Squibb, 2014) Because the technology is similar but used differently, BMS would be considered a close competitor who currently has the advantage of having four targeted specific drugs and 12 other oncology and immune-oncology in various trial phases.
Holmes will only say–and this is more than she has ever said before–that her company uses "the same fundamental chemical methods" as existing labs do. Its advances relate to "optimizing the chemistry" and "leveraging software" to permit those conventional methods to work with tiny sample volumes. lab-on-a-chip technology, which allows multiple measurements to be taken from tiny amounts of liquid on a single microchip” (Loria, 2015). Since the development of this technology in 2003 by Elisabeth Holmes, the organisation has gone on to conduct over 3.5 million tests in Walgreens and the Cleveland Clinics throughout America. They have worked with over 9,000 doctors and over 150 of the tests cost less than $10. They have voluntarily submitting tests to the FDA, even though they didn’t need to and opened up to regulators like no lab before. They received their first FDA clearance this summer (Theranos, 2015). Theranos has contributed to both the economy and to society at large by providing employment to hundreds of people, by giving convenient and affordable access to blood analysis and paving the way for how medical diagnostics will be more attainable the